南方医科大学学报
南方醫科大學學報
남방의과대학학보
JOURNAL OF SOUTHERN MEDICAL UNIVERSITY
2014年
4期
463-467
,共5页
付志豪%武伦%乔正荣%周世骥%李生伟
付誌豪%武倫%喬正榮%週世驥%李生偉
부지호%무륜%교정영%주세기%리생위
肝肿瘤%缺氧诱导因子%高强度聚焦超声%残余肿瘤
肝腫瘤%缺氧誘導因子%高彊度聚焦超聲%殘餘腫瘤
간종류%결양유도인자%고강도취초초성%잔여종류
liver neoplasms%hypoxia-inducible factor%high-intensity focused ultrasound%residual tumor
目的:探讨缺氧诱导因子(HIF1α、HIF2α)在高强度聚焦超声(HIFU)治疗后的残余肿瘤中的变化。方法建立肝癌HpG2细胞株裸鼠移植瘤模型30只,采用CZF-Ⅱ型HIFU治疗仪治疗,随机分为对照组、治疗后1 d、3 d、5 d、1周、2周组。HE染色观察标本病理变化;免疫组化、Western blotting和实时荧光定量PCR技术检测HIF1α、HIF2α蛋白和mRNA水平。结果 HE染色表明治疗后有残余肿瘤细胞和大片坏死区域。免疫组化表明HIF1α、HIF2α蛋白在各组中出现强弱不同表达。Western blotting和RT-PCR显示HIF1α蛋白和mRNA水平在治疗后1~3 d表达逐渐升高,在3 d组达到高峰,与其他组比较有统计学意义(P<0.05),在5 d、1周、2周组逐渐下降。同时,HIF2α蛋白和mRNA在治疗后1 d、3 d组与对照组之间无明显差异(P>0.05),在5 d、1周、2周组表达逐渐升高,与对照组之间有差异(P<0.05)。结论 HIFU治疗后的残余肿瘤,HIF1α、HIF2α在不同时间出现的变化,可能与残癌中发生的细胞凋亡和血管生成有关。
目的:探討缺氧誘導因子(HIF1α、HIF2α)在高彊度聚焦超聲(HIFU)治療後的殘餘腫瘤中的變化。方法建立肝癌HpG2細胞株裸鼠移植瘤模型30隻,採用CZF-Ⅱ型HIFU治療儀治療,隨機分為對照組、治療後1 d、3 d、5 d、1週、2週組。HE染色觀察標本病理變化;免疫組化、Western blotting和實時熒光定量PCR技術檢測HIF1α、HIF2α蛋白和mRNA水平。結果 HE染色錶明治療後有殘餘腫瘤細胞和大片壞死區域。免疫組化錶明HIF1α、HIF2α蛋白在各組中齣現彊弱不同錶達。Western blotting和RT-PCR顯示HIF1α蛋白和mRNA水平在治療後1~3 d錶達逐漸升高,在3 d組達到高峰,與其他組比較有統計學意義(P<0.05),在5 d、1週、2週組逐漸下降。同時,HIF2α蛋白和mRNA在治療後1 d、3 d組與對照組之間無明顯差異(P>0.05),在5 d、1週、2週組錶達逐漸升高,與對照組之間有差異(P<0.05)。結論 HIFU治療後的殘餘腫瘤,HIF1α、HIF2α在不同時間齣現的變化,可能與殘癌中髮生的細胞凋亡和血管生成有關。
목적:탐토결양유도인자(HIF1α、HIF2α)재고강도취초초성(HIFU)치료후적잔여종류중적변화。방법건립간암HpG2세포주라서이식류모형30지,채용CZF-Ⅱ형HIFU치료의치료,수궤분위대조조、치료후1 d、3 d、5 d、1주、2주조。HE염색관찰표본병리변화;면역조화、Western blotting화실시형광정량PCR기술검측HIF1α、HIF2α단백화mRNA수평。결과 HE염색표명치료후유잔여종류세포화대편배사구역。면역조화표명HIF1α、HIF2α단백재각조중출현강약불동표체。Western blotting화RT-PCR현시HIF1α단백화mRNA수평재치료후1~3 d표체축점승고,재3 d조체도고봉,여기타조비교유통계학의의(P<0.05),재5 d、1주、2주조축점하강。동시,HIF2α단백화mRNA재치료후1 d、3 d조여대조조지간무명현차이(P>0.05),재5 d、1주、2주조표체축점승고,여대조조지간유차이(P<0.05)。결론 HIFU치료후적잔여종류,HIF1α、HIF2α재불동시간출현적변화,가능여잔암중발생적세포조망화혈관생성유관。
Objective To study the changes in hypoxia-inducible factor (HIF1α, HIF2α) in the residual tumor cells in nude mice bearing hepatocellular carcinoma (HCC) following treatment with high-intensity focused ultrasound (HIFU). Methods Thirty nude mice bearing human HCC received treatment with HIFU. At 1, 3, and 5 days and 1 and 2 weeks after the treatment, the mice were examined for pathological changes of the residual tumor with HE staining; SP immunohistochemistry, Western blotting and real-time quantitative PCR were used to detect the protein and mRNA expressions of HIF1α and HIF2α in the tumor. Results HE staining revealed the presence of residual tumor cells and large necrotic areas after the treatment. Immunohistochemistry showed a gradual increment of HIF1αprotein and mRNA expressions after the treatment, reaching the peak level at 3 days (P<0.05) followed by progressive reduction at 5 days and 1 and 2 weeks. HIF2αexpressions at either the protein or mRNA levels exhibited no significant changes within 3 days after the treatment (P>0.05) but increased significantly at 5 days and 1 and 2 weeks (P<0.05). Conclusion The changes of HIF1αand HIF2αin the residual tumor after HIFU treatment in nude mice bearing HCC can be associated with tumor cell apoptosis and angiogenesis after the treatment.